Ortega-Gutiérrez S - Search Results

1

Chemoproteomic Approach to Explore the Target Profile of GPCR ligands: Application to 5-HT1A and 5-HT6 Receptors.

Gamo AM, González-Vera JA, Rueda-Zubiaurre A, Alonso D, Vázquez-Villa H, Martín-Couce L, Palomares Ó, López JA, Martín-Fontecha M, Benhamú B, López-Rodríguez ML, Ortega-Gutiérrez S. Gamo AM, et al. Chemistry. 2016 Jan 22;22(4):1313-21. doi: 10.1002/chem.201503101. Epub 2015 Nov 12. Chemistry. 2016. PMID: 26560738

2

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Lastres-Becker I, González S, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. J Med Chem. 2001 Dec 20;44(26):4505-8. doi: 10.1021/jm015545y. J Med Chem. 2001. PMID: 11741470

3

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.

de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML, Ramos JA. de Lago E, et al. Eur J Pharmacol. 2002 Aug 2;449(1-2):99-103. doi: 10.1016/s0014-2999(02)01996-9. Eur J Pharmacol. 2002. PMID: 12163112

4

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818. J Med Chem. 2003. PMID: 12672252

5

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. Eur J Med Chem. 2003 Apr;38(4):403-12. doi: 10.1016/s0223-5234(03)00045-x. Eur J Med Chem. 2003. PMID: 12750028

6

Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin.

Fowler CJ, Tiger G, López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Ramos JA. Fowler CJ, et al. J Enzyme Inhib Med Chem. 2003 Jun;18(3):225-31. doi: 10.1080/1475636031000080216. J Enzyme Inhib Med Chem. 2003. PMID: 14506913 Free article.

7

VR1 receptor modulators as potential drugs for neuropathic pain.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S. López-Rodríguez ML, et al. Mini Rev Med Chem. 2003 Nov;3(7):729-48. doi: 10.2174/1389557033487845. Mini Rev Med Chem. 2003. PMID: 14529514 Review.

8

Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.

Ruiz-Llorente L, Ortega-Gutiérrez S, Viso A, Sánchez MG, Sánchez AM, Fernández C, Ramos JA, Hillard C, Lasunción MA, López-Rodríguez ML, Díaz-Laviada I. Ruiz-Llorente L, et al. Br J Pharmacol. 2004 Feb;141(3):457-67. doi: 10.1038/sj.bjp.0705628. Epub 2004 Jan 12. Br J Pharmacol. 2004. PMID: 14718261 Free PMC article.

9

Involvement of cannabinoids in cellular proliferation.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Díaz-Laviada I. López-Rodríguez ML, et al. Mini Rev Med Chem. 2005 Jan;5(1):97-106. doi: 10.2174/1389557053402819. Mini Rev Med Chem. 2005. PMID: 15638794 Review.

10

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis.

Ortega-Gutiérrez S, Molina-Holgado E, Arévalo-Martín A, Correa F, Viso A, López-Rodríguez ML, Di Marzo V, Guaza C. Ortega-Gutiérrez S, et al. FASEB J. 2005 Aug;19(10):1338-40. doi: 10.1096/fj.04-2464fje. Epub 2005 Jun 7. FASEB J. 2005. PMID: 15941768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters